These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12200852)

  • 1. Crystal structure and synthesis of 17 alpha-acetoxy-4-bromopregn-4-ene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2002 Aug; 18(8):963-4. PubMed ID: 12200852
    [No Abstract]   [Full Text] [Related]  

  • 2. Crystal structure and synthesis of 17 alpha-(5-bromovaleroyloxy)-16 beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Jul; 17(7):911-2. PubMed ID: 11708132
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal structure and synthesis of 17alpha-hexanoyloxy-16beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2001 Oct; 17(10):1245-6. PubMed ID: 11990608
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiandrogen. III. 11-oxapregnane steroids.
    Takegawa S; Koizumi N; Mieda M; Shibata K
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):746-8. PubMed ID: 8681406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of doisynolic acid and the structure of other products formed during its synthesis.
    Chi DY; Wilson SR; Katzenellenbogen JA
    Steroids; 1995 Mar; 60(3):261-4. PubMed ID: 7792828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected binding orientation of bulky-B-ring anti-androgens and implications for future drug targets.
    Duke CB; Jones A; Bohl CE; Dalton JT; Miller DD
    J Med Chem; 2011 Jun; 54(11):3973-6. PubMed ID: 21506597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure and synthesis of 17alpha-(5-chlorovaleroyloxy)-16beta-methylpregna-4,6-diene-3,20-dione.
    Soriano-García M; Ramírez E; Bratoeff E; Cabeza M; Aguirre-Hernández G
    Anal Sci; 2003 Apr; 19(4):639-40. PubMed ID: 12725409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An expeditious and atom-economical synthesis of a new generation of substituted [4.6.4.6]fenestradienes.
    Charpenay M; Boudhar A; Blond G; Suffert J
    Angew Chem Int Ed Engl; 2012 Apr; 51(18):4379-82. PubMed ID: 22438292
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a benzopyran-containing androgen receptor antagonist to treat antiandrogen-resistant prostate cancer.
    Oh S; Nam HJ; Park J; Beak SH; Park SB
    ChemMedChem; 2010 Apr; 5(4):529-33. PubMed ID: 20135667
    [No Abstract]   [Full Text] [Related]  

  • 10. First synthesis of separable isomeric testosterone dimers showing differential activities on prostate cancer cells.
    Bastien D; Leblanc V; Asselin E; Bérubé G
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2078-81. PubMed ID: 20226660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of the first ferrocenyl-aryl-hydantoin derivatives of the nonsteroidal antiandrogen nilutamide.
    Payen O; Top S; Vessières A; Brulé E; Plamont MA; McGlinchey MJ; Müller-Bunz H; Jaouen G
    J Med Chem; 2008 Mar; 51(6):1791-9. PubMed ID: 18303829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient one-pot synthesis generating 4-ene-3,6-dione functionalised steroids from steroidal 5-en-3beta-ols using a modified Jones oxidation methodology.
    Hunter AC; Priest SM
    Steroids; 2006 Jan; 71(1):30-3. PubMed ID: 16183090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and identification of two new epimer from the mother liquid of megestrol acetate].
    Yang ZD; Chen H; Wang YF; Lin LB; Li YC
    Yao Xue Xue Bao; 2005 Sep; 40(9):830-3. PubMed ID: 16342686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional model of cytochrome P450 human aromatase.
    Loge C; Le Borgne M; Marchand P; Robert JM; Le Baut G; Palzer M; Hartmann RW
    J Enzyme Inhib Med Chem; 2005 Dec; 20(6):581-5. PubMed ID: 16408794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome.
    Goto T; Ohta K; Fujii S; Ohta S; Endo Y
    J Med Chem; 2010 Jul; 53(13):4917-26. PubMed ID: 20521823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
    Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and antiandrogenic activity of 17-deoxysteroids].
    Masuoka Y; Masuoka M; Goto G; Hiraga K; Nakayama R; Miki T; Sumi M
    Yakugaku Zasshi; 1983 Oct; 103(10):1046-53. PubMed ID: 6674485
    [No Abstract]   [Full Text] [Related]  

  • 19. Total syntheses of optically active 19-norsteroids. (+)-Estr-4-ene-3,17-dione and (+)13 beta-ethylgon-4-ene-3,17-dione.
    Micheli RA; Hajos ZG; Cohen N; Parrish DR; Portland LA; Sciamanna W; Scott MA; Wehrli PA
    J Org Chem; 1975 Mar; 40(6):675-81. PubMed ID: 1133631
    [No Abstract]   [Full Text] [Related]  

  • 20. Aromatase inhibitors: synthesis, biological activity, and binding mode of azole-type compounds.
    Furet P; Batzl C; Bhatnagar A; Francotte E; Rihs G; Lang M
    J Med Chem; 1993 May; 36(10):1393-400. PubMed ID: 8496907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.